Formulation for Co-Administration of Q-GRFT and Tenofovir
US-2024374681-A1 · Nov 14, 2024 · US
US2020277342A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020277342-A1 |
| Application number | US-202016839741-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 3, 2020 |
| Priority date | Jun 24, 2016 |
| Publication date | Sep 3, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum. Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum.
Opening claim text (preview).
What is claimed is: 1 . A method of increasing production of a nucleic acid molecule in a cell, comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion, (b) incubating the cell with one or more unnatural nucleoside triphosphates, and (c) transporting the one or more unnatural nucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter. 2 . The method of claim 1 , wherein the nucleic acid molecule comprises DNA. 3 . The method of claim 1 , wherein the nucleic acid molecule comprises RNA. 4 . The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum. 5 . The method of claim 1 , wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues. 6 . The method of claim 1 , wherein the deletion is a N-terminal deletion. 7 . The method of claim 1 , wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4. 8 . The method of claim 1 , wherein the cell is an engineered cell. 9 . The method of claim 8 , wherein the engineered cell is E. coli. 10 . The method of claim 1 , wherein the cell is a prokaryotic cell. 11 . The method of claim 10 , wherein the cell is E. coli. 12 . The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base selected from the group consisting of 13 . The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is 14 . The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is 15 . The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from the group consisting of 16 . The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is 17 . The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is 18 . A method of increasing production of a DNA nucleic acid molecule in a cell comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion, (b) incubating the cell with one or more unnatural 2′-deoxyribonucleoside triphosphates, and (c) transporting the one or more unnatural 2′-deoxyribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprise a base selected from the group consisting of: 19 . The method of claim 18 , wherein the cell is E. coli. 20 . The method of claim 18 , wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum. 21 . The method of claim 18 , wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues. 22 . The method of claim 18 , wherein the deletion is a N-terminal deletion. 23 . The method of claim 18 , wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4. 24 . A method of increasing production of a RNA nucleic acid molecule in a cell, comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion, (b) incubating the cell with one or more unnatural ribonucleoside triphosphates, and (c) transporting the one or more unnatural ribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural ribonucleoside triphosphates comprise a base selected from the group consisting of: 25 . The method of claim 24 , wherein the cell is E. coli. 26 . The method of claim 24 , wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum. 27 . The method of claim 24 , wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues. 28 . The method of claim 24 , wherein the deletion is a N-terminal deletion. 29 . The method of claim 24 , wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4.
Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title
from algae · CPC title
Stable introduction of foreign DNA into chromosome · CPC title
involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title
Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.